Evaluation of an Epitypified Ophiocordyceps formosana (Cordyceps s.l.)‎ for Its Pharmacological Potential

Abstract EN

The substantial merit of Cordyceps s.l.

spp.

in terms of medicinal benefits is largely appreciated.

Nevertheless, only few studies have characterized and examined the clinical complications of the use of health tonics containing these species.

Here, we epitypified C.

formosana isolates that were collected and characterized as Ophiocordyceps formosana based on morphological characteristics, molecular phylogenetic analyses, and metabolite profiling.

Thus, we renamed and transferred C.

formosana to the new protologue Ophiocordyceps formosana (Kobayasi & Shimizu) Wang, Tsai, Tzean & Shen comb.

nov.

Additionally, the pharmacological potential of O.

formosana was evaluated based on the hot-water extract from its mycelium.

The relative amounts of the known bioactive ingredients that are unique to Cordyceps s.l.

species in O.

formosana were found to be similar to the amounts in O.

sinensis and C.

militaris, indicating the potential applicability of O.

formosana for pharmacological uses.

Additionally, we found that O.

formosana exhibited antioxidation activities in vitro and in vivo that were similar to those of O.

sinensis and C.

militaris.

Furthermore, O.

formosana also displayed conspicuously effective antitumor activity compared with the tested Cordyceps s.l.

species.

Intrinsically, O.

formosana exhibited less toxicity than the other Cordyceps species.

Together, our data suggest that the metabolites of O.

formosana may play active roles in complementary medicine.